Immupharma PLC Grant of Options (6023K)
22 Diciembre 2022 - 1:55AM
UK Regulatory
TIDMIMM
RNS Number : 6023K
Immupharma PLC
22 December 2022
22 December 2022
ImmuPharma PLC
("ImmuPharma" or the "Company")
Grant of Share Options
ImmuPharma PLC (LSE:IMM), the specialist drug discovery and
development company, announces the grant of share options as
follows.
The Remuneration Committee (comprising the Non Executive
Directors) has determined to award Share Options to the Executive
Directors with exercise prices and conditions which reflect the
underlying objective of restoring and enhancing shareholder value
as follows:
Tim McCarthy 1,800,000 share options (exercise price GBP0.05)
Tim McCarthy 1,800,000 share options (exercise price GBP0.11)
Tim Franklin 1,575,000 share options (exercise price GBP0.05)
Tim Franklin 1,575,000 share options (exercice price GBP0.11)
Vesting & Performance conditions:
-- 3 year vesting period; and
-- 1st patient dosed in the next P140 (Lupuzor(TM)) clinical trial.
ENDS
For further information please contact:
ImmuPharma PLC ( www.immupharma.com ) +44 (0) 207 206 2650
Tim McCarthy, Chief Executive Officer
Lisa Baderoon, Head of Investor Relations + 44 (0) 7721 413496
SPARK Advisory Partners Limited (NOMAD)
Neil Baldwin +44 (0) 203 36 8 3550
Stanford Capital Partners (Joint Broker)
Patrick Claridge, John Howes, Bob Pountney +44 (0) 203 650 3650
SI Capital (Joint Broker)
Nick Emerson +44 (0) 1483 413500
Notes to Editors
About ImmuPharma PLC
ImmuPharma PLC (LSE AIM: IMM) is a specialty biopharmaceutical
company that discovers and develops peptide-based therapeutics. The
Company's portfolio includes novel peptide therapeutics for
autoimmune diseases and anti-infectives. The lead program,
Lupuzor(TM), is a first-in class autophagy immunomodulator for the
treatment of Lupus and preclinical analysis suggest therapeutic
activity for many other autoimmune diseases that share the same
autophagy mechanism of action.
For additional information about ImmuPharma please visit
www.immupharma .co.uk
ImmuPharma's LEI (Legal Entity Identifier) code :
213800VZKGHXC7VUS895.
Notification and public disclosure of transactions by persons
discharging managerial responsibilities and persons closely
associated with them.
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Tim McCarthy
--------------------------------- --------------------------------------------
2 Reason for the notification
-------------------------------------------------------------------------------
a) Position / status Chairman and Chief Executive Officer
--------------------------------- --------------------------------------------
b) Initial notification Initial notification
/ Amendment
--------------------------------- --------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-------------------------------------------------------------------------------
a) Name ImmuPharma PLC
--------------------------------- --------------------------------------------
b) LEI 213800VZKGHXC7VUS895
--------------------------------- --------------------------------------------
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
-------------------------------------------------------------------------------
a) Description of the Ordinary Shares of 1p each
financial instrument
, type of instrument
ISIN: GB0033711010
Identification code
--------------------------------- --------------------------------------------
b) Nature of the transaction Grant of share options over new Ordinary
Shares
--------------------------------- --------------------------------------------
c) Price(s) and volume(s) Exercise Price Volume
--------------------------------- -------------------------- ----------------
5 pence 1,800,000
----------------------------------------------------------------- ----------------
11 pence 1,800,000
----------------------------------------------------------------- ----------------
d) Aggregated information N/A
- Aggregated volume
- Price
--------------------------------- --------------------------------------------
e) Date of the transaction 22 December 2022
--------------------------------- --------------------------------------------
f) Place of the transaction n/a
--------------------------------- --------------------------------------------
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Tim Franklin
--------------------------------- --------------------------------------------
2 Reason for the notification
-------------------------------------------------------------------------------
a) Position / status Chief Operating Officer
--------------------------------- --------------------------------------------
b) Initial notification Initial notification
/ Amendment
--------------------------------- --------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-------------------------------------------------------------------------------
a) Name ImmuPharma PLC
--------------------------------- --------------------------------------------
b) LEI 213800VZKGHXC7VUS895
--------------------------------- --------------------------------------------
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
-------------------------------------------------------------------------------
a) Description of the Ordinary Shares of 1p each
financial instrument
, type of instrument
ISIN: GB0033711010
Identification code
--------------------------------- --------------------------------------------
b) Nature of the transaction Grant of share options over new Ordinary
Shares
--------------------------------- --------------------------------------------
c) Price(s) and volume(s) Exercise Price Volume
--------------------------------- -------------------------- ----------------
5 pence 1,575,000
----------------------------------------------------------------- ----------------
11 pence 1,575,000
----------------------------------------------------------------- ----------------
d) Aggregated information N/A
- Aggregated volume
- Price
--------------------------------- --------------------------------------------
e) Date of the transaction 22 December 2022
--------------------------------- --------------------------------------------
f) Place of the transaction n/a
--------------------------------- --------------------------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHUUOBRUBUUURA
(END) Dow Jones Newswires
December 22, 2022 02:55 ET (07:55 GMT)
Immupharma (AQSE:IMM.GB)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Immupharma (AQSE:IMM.GB)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
